CN116210898A - Compound fungal polysaccharide product for regulating glycolipid metabolism through immune activation - Google Patents
Compound fungal polysaccharide product for regulating glycolipid metabolism through immune activation Download PDFInfo
- Publication number
- CN116210898A CN116210898A CN202310391367.XA CN202310391367A CN116210898A CN 116210898 A CN116210898 A CN 116210898A CN 202310391367 A CN202310391367 A CN 202310391367A CN 116210898 A CN116210898 A CN 116210898A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- fungus
- polysaccharide product
- morchella
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 36
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 36
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 36
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 28
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 229930186217 Glycolipid Natural products 0.000 title claims abstract description 25
- 230000004060 metabolic process Effects 0.000 title claims abstract description 25
- 230000005934 immune activation Effects 0.000 title claims abstract description 20
- 150000001875 compounds Chemical class 0.000 title claims abstract description 14
- 230000002538 fungal effect Effects 0.000 title claims description 13
- 239000000843 powder Substances 0.000 claims abstract description 213
- 241000233866 Fungi Species 0.000 claims abstract description 59
- 240000000588 Hericium erinaceus Species 0.000 claims abstract description 21
- 235000007328 Hericium erinaceus Nutrition 0.000 claims abstract description 21
- 241000121220 Tricholoma matsutake Species 0.000 claims abstract description 20
- 229940046536 tree pollen allergenic extract Drugs 0.000 claims abstract description 20
- 241001327634 Agaricus blazei Species 0.000 claims abstract description 19
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 19
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 19
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 19
- 244000197580 Poria cocos Species 0.000 claims abstract description 19
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 19
- 235000008434 ginseng Nutrition 0.000 claims abstract description 19
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims abstract description 18
- 235000017491 Bambusa tulda Nutrition 0.000 claims abstract description 18
- 241000221638 Morchella Species 0.000 claims abstract description 18
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims abstract description 18
- 241000221987 Russula Species 0.000 claims abstract description 18
- 244000223977 Tuber melanosporum Species 0.000 claims abstract description 18
- 235000002777 Tuber melanosporum Nutrition 0.000 claims abstract description 18
- 239000011425 bamboo Substances 0.000 claims abstract description 18
- 240000001462 Pleurotus ostreatus Species 0.000 claims abstract description 5
- 235000001603 Pleurotus ostreatus Nutrition 0.000 claims abstract description 5
- 241000208340 Araliaceae Species 0.000 claims description 17
- 241001330002 Bambuseae Species 0.000 claims description 16
- 241000117280 Naematelia aurantialba Species 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 4
- 241001148715 Lamarckia aurea Species 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 230000000259 anti-tumor effect Effects 0.000 abstract description 3
- 235000007685 Pleurotus columbinus Nutrition 0.000 abstract description 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract description 2
- 210000003719 b-lymphocyte Anatomy 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 230000005965 immune activity Effects 0.000 abstract description 2
- 210000004698 lymphocyte Anatomy 0.000 abstract description 2
- 230000009466 transformation Effects 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 2
- 244000082204 Phyllostachys viridis Species 0.000 abstract 2
- 241001506047 Tremella Species 0.000 abstract 1
- 239000000047 product Substances 0.000 description 23
- 230000000694 effects Effects 0.000 description 19
- 241000699670 Mus sp. Species 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 5
- 240000002769 Morchella esculenta Species 0.000 description 5
- 235000002779 Morchella esculenta Nutrition 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000222351 Pleurotus cornucopiae Species 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 208000017971 listlessness Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000003867 tiredness Effects 0.000 description 2
- 208000016255 tiredness Diseases 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 235000005638 Austrian pine Nutrition 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241001313710 Dictyophora indusiata Species 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 201000009623 Myopathy Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000008565 Pinus banksiana Nutrition 0.000 description 1
- 244000019397 Pinus jeffreyi Species 0.000 description 1
- 235000013264 Pinus jeffreyi Nutrition 0.000 description 1
- 235000008578 Pinus strobus Nutrition 0.000 description 1
- 235000008585 Pinus thunbergii Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 235000014030 Podocarpus spicatus Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical group 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000037841 lung tumor Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- -1 microelements Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000004565 tumor cell growth Effects 0.000 description 1
- 206010046459 urethral obstruction Diseases 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a compound fungus polysaccharide product for regulating glycolipid metabolism through immune activation, which comprises the following components in parts by weight: 5-15 parts of hericium erinaceus powder, 5-15 parts of poria cocos powder, 5-15 parts of bamboo fungus powder, 5-15 parts of agaricus blazei murill powder, 3-10 parts of cordyceps militaris powder, 3-10 parts of ash tree pollen, 3-10 parts of white ginseng fungus powder, 3-10 parts of tremella aurantifolia powder, 3-8 parts of morchella powder, 3-8 parts of russula powder, 3-8 parts of black truffle powder and 3-8 parts of pine mushroom powder; according to the invention, the compound fungus polysaccharide product for regulating glycolipid metabolism through immune activation is prepared from hericium erinaceus powder, poria cocos powder, bamboo fungus powder, agaricus blazei murill powder, cordyceps militaris powder, ash tree pollen, white ginseng fungus powder, pleurotus ostreatus powder, morchella powder, russula powder, black truffle powder and tricholoma matsutake powder, so that the immune activity can be stimulated, the glycolipid metabolism can be regulated, lymphocyte transformation is promoted, T cells and B cells are activated, and the formation of antibodies is promoted, so that the antitumor effect is realized.
Description
Technical Field
The invention relates to the technical field of health products, in particular to a compound fungus polysaccharide product for regulating glycolipid metabolism through immune activation.
Background
The fungus polysaccharide has extremely strong repairing effect on cells. The fungus polysaccharide health food can timely supplement substances such as polysaccharide lacking in the interstitial space of cells, so that damaged cells can be timely repaired, and the purposes of keeping cell health, prolonging cell life and realizing human health are achieved. Experiments of Shanghai medical university Li Rui and the like show that the fungus polysaccharide can obviously improve the fluidity and the sealing degree of cell membranes, the sealing degree is improved by 11 percent, the fluidity is improved by 32 percent, and the cell membrane fluidity and the sealing property are improved after the aged cells are cultured by the fungus polysaccharide, which indicates that the physiological functions of the cells are improved.
The fungal polysaccharide also has hypolipidemic properties: reducing the content of cholesterol and triglyceride, reducing the deposition of lipid on the wall of a blood vessel, inhibiting platelet aggregation and reducing the viscosity of blood, but the current commercial fungal polysaccharide products have unsatisfactory effects of regulating the metabolism of glycolipid;
the invention provides a compound fungus polysaccharide product for regulating glycolipid metabolism through immune activation, which has the health care effect of regulating glycolipid metabolism and solves the problem of unsatisfactory effect of the current health care products.
Disclosure of Invention
The present invention aims to provide a complex fungal polysaccharide product for regulating glycolipid metabolism by immune activation, which solves the problems set forth in the background art.
In order to achieve the above purpose, the present invention provides the following technical solutions: a compound fungus polysaccharide product for regulating glycolipid metabolism through immune activation comprises the following components in parts by weight: 5-15 parts of hericium erinaceus powder, 5-15 parts of poria cocos powder, 5-15 parts of bamboo fungus powder, 5-15 parts of agaricus blazei murill powder, 3-10 parts of cordyceps militaris powder, 3-10 parts of ash tree pollen, 3-10 parts of white ginseng fungus powder, 3-10 parts of golden top side fungus powder, 3-8 parts of morchella powder, 3-8 parts of russula powder, 3-8 parts of black truffle powder and 3-8 parts of pine mushroom powder.
Wherein the composition comprises the following components in parts by weight: 10 parts of hericium erinaceus powder, 10 parts of poria cocos powder, 10 parts of bamboo fungus powder, 10 parts of agaricus blazei murill powder, 3 parts of cordyceps militaris powder, 3 parts of ash tree pollen, 3 parts of white ginseng fungus powder, 3 parts of tremella aurantialba powder, 5 parts of morchella powder, 5 parts of russula powder, 5 parts of black truffle powder and 5 parts of pine mushroom powder.
Wherein the composition comprises the following components in parts by weight: 10 parts of hericium erinaceus powder, 10 parts of poria cocos powder, 10 parts of bamboo fungus powder, 10 parts of agaricus blazei murill powder, 6 parts of cordyceps militaris powder, 6 parts of ash tree pollen, 6 parts of white ginseng fungus powder, 6 parts of tremella aurantialba powder, 5 parts of morchella powder, 5 parts of russula powder, 5 parts of black truffle powder and 5 parts of pine mushroom powder.
Wherein the composition comprises the following components in parts by weight: 10 parts of hericium erinaceus powder, 10 parts of poria cocos powder, 10 parts of bamboo fungus powder, 10 parts of agaricus blazei murill powder, 10 parts of cordyceps militaris powder, 10 parts of ash tree pollen, 10 parts of white ginseng fungus powder, 10 parts of tremella aurantialba powder, 5 parts of morchella powder, 5 parts of russula powder, 5 parts of black truffle powder and 5 parts of pine mushroom powder.
Wherein, a compound fungus polysaccharide product for regulating glycolipid metabolism by immune activation, the preparation method of the product comprises the following steps:
s1, respectively weighing hericium erinaceus powder, poria cocos powder, bamboo fungus powder, agaricus blazei murill powder, cordyceps militaris powder, ash tree pollen, white ginseng fungus powder, oyster mushroom powder, morchella powder, russula powder, black truffle powder and tricholoma matsutake powder according to parts by weight for later use;
s2, sieving with a 60-120 mesh sieve, and uniformly mixing to obtain a mixed raw material;
s3, tabletting the mixed raw materials through a tablet press to obtain a composite fungus polysaccharide product for regulating glycolipid metabolism through immune activation.
The hericium erinaceus powder contains a large amount of unsaturated fatty acid, can effectively reduce cholesterol in blood, and has good effects of treating hypertension and hyperlipidemia; oligosaccharide contained in Hericium erinaceus powder can be used for treating chronic atrophic gastritis; hericium erinaceus powder contains a large amount of polypeptides, and can prevent cancer.
Poria powder has effect in promoting urination, and has sweet taste, and can promote urination and resist bacteria, and is mainly used for treating symptoms such as body edema, frequent urination, obstruction of urethra, dizziness, palpitation and short breath caused by cold, heat, deficiency and excess constitution. Also has tranquillizing effect, and Poria has effects of invigorating heart and spleen, invigorating spleen, promoting qi and blood circulation, and tranquilizing mind. Can be used for treating heart and spleen deficiency caused by restlessness of heart and mind, or palpitation and insomnia. In addition, the poria cocos powder has the effects of strengthening spleen and nourishing stomach, tonifying spleen and middle-jiao, excreting dampness and stopping diarrhea and the like, and has certain effects on anorexia, tiredness, diarrhea and loose stool caused by spleen deficiency and excessive dampness.
The Dictyophora Indusiata powder has effects of invigorating qi and spleen, promoting salivation, quenching thirst, and tranquilizing mind. It can be used for treating listlessness, limb debilitation, loose stool, cough, debilitation, spontaneous perspiration, and palpitation, insomnia, dizziness, dry mouth, dry throat, tinnitus, constipation, etc. due to deficiency of both qi and blood or deficiency of both qi and yin.
The agaricus blazei murill powder can enhance the immune function of a human body, enhance the autoimmune function of the human body through enhancing the function of a mononuclear macrophage system, inhibit cell division and regulate immune system reaction, thereby resisting and interfering virus growth; can promote hematopoietic function of human bone marrow, inhibit bone marrow hematopoietic function by improving chemotherapy to make peripheral hemoglobin concentration, total number of platelet white cells, and trend to normal value, and inhibit tumor cells, and can strengthen body constitution and improve health after long-term administration; has anticancer and antitumor effects, and contains polysaccharides and steroids as main ingredients, and can directly promote immunocyte activity, inhibit tumor cell growth, and have remarkable inhibiting effect on various tumor cells.
The Cordyceps militaris powder can help the body of a person to trend to a normal direction to help the body to improve immunity, has good curative effect on treating chronic trachitis and pneumonia, can eliminate bacteria, remove radicals, reduce blood pressure and blood sugar, and has good health care effect.
The ash tree pollen mainly has the functions of replenishing qi to invigorate the spleen, tonifying deficiency and strengthening the body resistance, so that the ash tree pollen is mainly used for treating spleen deficiency and qi weakness, tiredness and hypodynamia, listlessness and lazy speaking, diet reduction and abdominal distension after eating, and can be applied to some tumor patients for radiotherapy or chemotherapy.
The white ginseng fungus powder has the effects of promoting the production of body fluid, nourishing yin, clearing deficiency heat, tonifying qi and strengthening body, and particularly has good effects on cough caused by semen deficiency and lung dryness. Can also be used for treating thirst, and has good relieving effect on constipation caused by dry stool.
The Pleurotus cornucopiae powder contains multiple nutritional components such as protein, vitamins and minerals, wherein the content of amino acids is especially rich, the content of essential amino acids is high, and the Pleurotus cornucopiae powder belongs to a high-nutrition and low-calorie food, has the functions of reducing blood pressure and cholesterol content after long-term eating, and is an ideal health food for old people suffering from cardiovascular diseases and obesity. Can be used as medicine for treating weak wilt (myopathy) and dysentery. Has tonic effect.
Morchella esculenta powder has a certain effect of improving the immunity of organisms, because Morchella esculenta is rich in a certain amount of mucilaginous polysaccharides, and the mucilaginous polysaccharides can play a positive role in promoting the generation of immune substances. Therefore, if the Morchella esculenta is properly eaten to supplement mucopolysaccharide, the production of immune substances is promoted, and the Morchella esculenta has positive effects on improving the immunity of organisms, so that the Morchella esculenta can play a role in reducing the incidence rate of infectious diseases.
The russula powder contains various amino acids essential to human beings. Has therapeutic effects on tumor, especially lung tumor, soreness of waist and legs, numbness of limbs, discomfort of tendons and bones, convulsion of limbs, blood tonifying, yin nourishing, refreshing and detoxicating, anemia, edema, malnutrition, and puerperal hemorrhage.
The black truffle powder contains abundant proteins, 18 amino acids, unsaturated fatty acids, multiple vitamins, microelements, mineral matters and the like, has extremely high nutritional and health care values, has the effects of supporting yang, regulating endocrine, enhancing immunity, resisting aging and fatigue, and has the effects of nourishing yin, regulating menstruation and maintaining beauty and keeping young for females.
The Tricholoma matsutake powder contains abundant vitamins, vitamin B1, vitamin B2, and vitamin C, and contains many crude proteins, pure proteins, and crude fat with anticancer effects. The Tricholoma matsutake has effects of strengthening body constitution, regulating stomach and intestine, and can be used for treating diabetes and resisting cancer.
Compared with the prior art, the invention has the beneficial effects that:
according to the invention, the compound fungus polysaccharide product for regulating glycolipid metabolism through immune activation is prepared from hericium erinaceus powder, poria cocos powder, bamboo fungus powder, agaricus blazei murill powder, cordyceps militaris powder, ash tree pollen, white ginseng fungus powder, pleurotus ostreatus powder, morchella powder, russula powder, black truffle powder and tricholoma matsutake powder, so that the immune activity can be stimulated, the glycolipid metabolism can be regulated, lymphocyte transformation is promoted, T cells and B cells are activated, and the formation of antibodies is promoted, so that the antitumor effect is realized.
Detailed Description
The following description of the technical solutions in the embodiments of the present invention will be clear and complete, and it is obvious that the described embodiments are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Example 1
A compound fungus polysaccharide product for regulating glycolipid metabolism through immune activation comprises the following components in parts by weight: 10 parts of hericium erinaceus powder, 10 parts of poria cocos powder, 10 parts of bamboo fungus powder, 10 parts of agaricus blazei murill powder, 3 parts of cordyceps militaris powder, 3 parts of ash tree pollen, 3 parts of white ginseng fungus powder, 3 parts of tremella aurantialba powder, 5 parts of morchella powder, 5 parts of russula powder, 5 parts of black truffle powder and 5 parts of pine mushroom powder.
A complex fungal polysaccharide product for regulating glycolipid metabolism by immune activation, the method of preparation comprising the steps of:
s1, respectively weighing hericium erinaceus powder, poria cocos powder, bamboo fungus powder, agaricus blazei murill powder, cordyceps militaris powder, ash tree pollen, white ginseng fungus powder, oyster mushroom powder, morchella powder, russula powder, black truffle powder and tricholoma matsutake powder according to parts by weight for later use;
s2, sieving with a 60-120 mesh sieve, and uniformly mixing to obtain a mixed raw material;
s3, tabletting the mixed raw materials through a tablet press to obtain a composite fungus polysaccharide product for regulating glycolipid metabolism through immune activation.
Example 2
A compound fungus polysaccharide product for regulating glycolipid metabolism through immune activation comprises the following components in parts by weight: 10 parts of hericium erinaceus powder, 10 parts of poria cocos powder, 10 parts of bamboo fungus powder, 10 parts of agaricus blazei murill powder, 6 parts of cordyceps militaris powder, 6 parts of ash tree pollen, 6 parts of white ginseng fungus powder, 6 parts of tremella aurantialba powder, 5 parts of morchella powder, 5 parts of russula powder, 5 parts of black truffle powder and 5 parts of pine mushroom powder.
The preparation method was the same as that of example 1, except that the parts by weight of the respective components were different.
Example 3
A compound fungus polysaccharide product for regulating glycolipid metabolism through immune activation comprises the following components in parts by weight: 10 parts of hericium erinaceus powder, 10 parts of poria cocos powder, 10 parts of bamboo fungus powder, 10 parts of agaricus blazei murill powder, 10 parts of cordyceps militaris powder, 10 parts of ash tree pollen, 10 parts of white ginseng fungus powder, 10 parts of tremella aurantialba powder, 5 parts of morchella powder, 5 parts of russula powder, 5 parts of black truffle powder and 5 parts of pine mushroom powder.
The preparation method was the same as that of example 1, except that the parts by weight of the respective components were different.
Experimental example
Mice were used for experiments, males, weighing 30-40g, were randomly divided into groups A, B, C, and D (four groups), 10 each, and fed conventionally.
Mice in group A were fed 5g of the product prepared in example 1 each day; group B mice were fed 5g of the product prepared in example 2 each day; mice in group C were fed 5g of the product prepared in example 3 each day; group D mice were fed 5g of normal saline each day for 60 days (during feeding the products prepared in examples 1-3 and normal saline, the mice were fed with the feed at regular intervals each day, ensuring their normal feeding needs).
The mice were observed for body weight, mental status, fecal morphology, and mortality, and the results are shown in the following table.
As can be seen from the table, after the products prepared in examples 1-3 are fed, the weight of the mice is obviously increased, the mental state is good, the excrement is not abnormal, after 60 days of feeding, the mice are not dead, after 60 days of feeding, the weight of the mice is not obviously increased, the mental state is low, the excrement is not formed, and death exists, so that the compound fungus polysaccharide product for regulating the metabolism of glycolipid through immune activation is prepared from hericium erinaceus powder, poria cocos powder, bamboo fungus powder, agaricus blazei powder, cordyceps militaris powder, ash tree pollen, white ginseng fungus powder, golden top side fungus powder, morchella powder, russian powder, black pine dew powder, and pine mushroom powder, so that the immunocompetence can be stimulated, the metabolism of glycolipid can be regulated, and the growth of the mice can be facilitated.
Although embodiments of the present invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made therein without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (5)
1. A compound fungus polysaccharide product for regulating glycolipid metabolism through immune activation is characterized by comprising the following components in parts by weight: 5-15 parts of hericium erinaceus powder, 5-15 parts of poria cocos powder, 5-15 parts of bamboo fungus powder, 5-15 parts of agaricus blazei murill powder, 3-10 parts of cordyceps militaris powder, 3-10 parts of ash tree pollen, 3-10 parts of white ginseng fungus powder, 3-10 parts of golden top side fungus powder, 3-8 parts of morchella powder, 3-8 parts of russula powder, 3-8 parts of black truffle powder and 3-8 parts of pine mushroom powder.
2. The complex fungal polysaccharide product according to claim 1, wherein the complex fungal polysaccharide product comprises the following components in parts by weight: 10 parts of hericium erinaceus powder, 10 parts of poria cocos powder, 10 parts of bamboo fungus powder, 10 parts of agaricus blazei murill powder, 3 parts of cordyceps militaris powder, 3 parts of ash tree pollen, 3 parts of white ginseng fungus powder, 3 parts of tremella aurantialba powder, 5 parts of morchella powder, 5 parts of russula powder, 5 parts of black truffle powder and 5 parts of pine mushroom powder.
3. The complex fungal polysaccharide product according to claim 1, wherein the complex fungal polysaccharide product comprises the following components in parts by weight: 10 parts of hericium erinaceus powder, 10 parts of poria cocos powder, 10 parts of bamboo fungus powder, 10 parts of agaricus blazei murill powder, 6 parts of cordyceps militaris powder, 6 parts of ash tree pollen, 6 parts of white ginseng fungus powder, 6 parts of tremella aurantialba powder, 5 parts of morchella powder, 5 parts of russula powder, 5 parts of black truffle powder and 5 parts of pine mushroom powder.
4. The complex fungal polysaccharide product according to claim 1, wherein the complex fungal polysaccharide product comprises the following components in parts by weight: 10 parts of hericium erinaceus powder, 10 parts of poria cocos powder, 10 parts of bamboo fungus powder, 10 parts of agaricus blazei murill powder, 10 parts of cordyceps militaris powder, 10 parts of ash tree pollen, 10 parts of white ginseng fungus powder, 10 parts of tremella aurantialba powder, 5 parts of morchella powder, 5 parts of russula powder, 5 parts of black truffle powder and 5 parts of pine mushroom powder.
5. A complex fungal polysaccharide product according to any of claims 1 to 4 for regulating glycolipid metabolism by immune activation, wherein the process for the preparation of the product comprises the steps of:
s1, respectively weighing hericium erinaceus powder, poria cocos powder, bamboo fungus powder, agaricus blazei murill powder, cordyceps militaris powder, ash tree pollen, white ginseng fungus powder, oyster mushroom powder, morchella powder, russula powder, black truffle powder and tricholoma matsutake powder according to parts by weight for later use;
s2, sieving with a 60-120 mesh sieve, and uniformly mixing to obtain a mixed raw material;
s3, tabletting the mixed raw materials through a tablet press to obtain a composite fungus polysaccharide product for regulating glycolipid metabolism through immune activation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310391367.XA CN116210898A (en) | 2023-04-13 | 2023-04-13 | Compound fungal polysaccharide product for regulating glycolipid metabolism through immune activation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310391367.XA CN116210898A (en) | 2023-04-13 | 2023-04-13 | Compound fungal polysaccharide product for regulating glycolipid metabolism through immune activation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116210898A true CN116210898A (en) | 2023-06-06 |
Family
ID=86571532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310391367.XA Withdrawn CN116210898A (en) | 2023-04-13 | 2023-04-13 | Compound fungal polysaccharide product for regulating glycolipid metabolism through immune activation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116210898A (en) |
-
2023
- 2023-04-13 CN CN202310391367.XA patent/CN116210898A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101473953B (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
| CN108272073A (en) | A kind of weight losing meal-replacing powder and preparation method thereof | |
| CN102144748A (en) | Five-color flour food with functions of excreting toxins, protecting liver and maintaining beauty | |
| CN105341668A (en) | Health-preserving quinoa porridge | |
| CN106616947A (en) | Cordyceps militaris composition | |
| CN102499291B (en) | Milk powder with functions of maintaining beauty and keeping young and improving immunity of organism and preparation method thereof | |
| CN111184214A (en) | Enzyme collagen coarse cereal, fruit and vegetable instant meal replacement porridge and making method thereof | |
| CN113186066A (en) | SOD wine capable of preserving health and tonifying kidney and preparation method thereof | |
| CN105285284A (en) | Grifola frondosa domestic fungus pressed candy and making method thereof | |
| CN102784163A (en) | Edible fungi compound polysaccharides health care treatment formula and preparation method thereof | |
| CN100479671C (en) | Method for preparing sour milk containing composite micron pollen pini and konjak for reducing-weight and lowering-blood sugar | |
| CN116210898A (en) | Compound fungal polysaccharide product for regulating glycolipid metabolism through immune activation | |
| CN109527091A (en) | The meal replacement powder and preparation method that a kind of suitable hyperglycemia, hypertension and people with hyperlipidemia are taken | |
| CN1339317A (en) | Poria oral liquor and its producing method | |
| CN107136490A (en) | A kind of peptide Chinese caterpillar fungus health product | |
| CN113842452A (en) | Medicine composition for treating diabetes and preparation method thereof | |
| CN106035686A (en) | Super chenopodium quinoa willd health-preservation plant milk | |
| CN105168482B (en) | It is a kind of for treating the composite bacterium powder of canker sore | |
| CN110585321A (en) | Traditional Chinese medicine composition for preventing and treating anemia and preparation method and application thereof | |
| CN104664325A (en) | Composite edible fungus nutrient tablet with anti-tumor effect | |
| CN115444017A (en) | Low-calorie composite nutritional meal replacement biscuit containing olive mushrooms and preparation method of biscuit | |
| CN105214074A (en) | A kind of Orally administered composition comprising Herba Cynomorii and ferment | |
| CN105077246B (en) | A kind of Moringa abstinence from alcohol composition and preparation method thereof | |
| CN1836675A (en) | Tablet containing lucid ganoderma and spirulina spp. ,and its preparation method | |
| Nandni et al. | Grifola frondosa: Nutraceutical and Medicinal Potential |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230606 |
|
| WW01 | Invention patent application withdrawn after publication |